Titelia

Holdings of Boxer Capital Management, LLC

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
45 in 2 countries
Top ten
68.1 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1Tango Therapeutics Inc 10,876,219227.5M $
2Kodiak Sciences Inc 1,361,00051.9M $
3Revolution Medicines Inc 500,00048.6M $
4Kymera Therapeutics Inc 329,10027.4M $
5Celcuity Inc 225,00025.7M $
6Surrozen Inc 766,31822.3M $
7Abivax SA 200,00022.3M $
8Terns Pharmaceuticals Inc 375,00019.8M $
9Vaxcyte Inc 325,00018.9M $
10Capricor Therapeutics Inc 590,00017.9M $
11Protagonist Therapeutics Inc 170,00017.9M $
12Vir Biotechnology Inc 1,866,00016.7M $
13Corvus Pharmaceuticals Inc 1,100,00016.1M $
14Praxis Precision Medicines Inc 46,45715M $
15PTC Therapeutics Inc 200,00013.6M $
16Precigen Inc 3,500,00013.5M $
17Amylyx Pharmaceuticals Inc 800,00011.1M $
18Opus Genetics Inc 2,250,00010.2M $
19Corcept Therapeutics Inc 250,00010.1M $
20Replimune Group Inc 1,175,0009M $
21Cogent Biosciences Inc 225,0008.7M $
22Palisade Bio Inc 4,799,8758.4M $
23Soleno Therapeutics Inc 200,0006.7M $
24Allogene Therapeutics Inc 2,725,0006.6M $
25Cytokinetics Inc 100,0006.6M $
26Contineum Therapeutics Inc 494,0006.5M $
27Apogee Therapeutics Inc 70,0005.9M $
28Relmada Therapeutics Inc 842,1065.9M $
29AVALO THERAPEUTICS INC 300,0004.5M $
30INOVIO PHARMACEUTICALS INC 2,370,1224.1M $
31Structure Therapeutics Inc 75,0003.6M $
32Sarepta Therapeutics Inc 150,0003.3M $
33Ocular Therapeutix Inc 350,0003M $
34AN2 Therapeutics Inc 749,0352.6M $
35CLENE INC 477,5152.4M $
36ORIC Pharmaceuticals Inc 176,5002.2M $
37Solid Biosciences Inc 300,0002.2M $
38Invivyd Inc 1,500,0002M $
39LB Pharmaceuticals Inc 70,0001.7M $
40Karyopharm Therapeutics Inc 302,5361.7M $
41Nurix Therapeutics Inc 100,0001.6M $
42Upstream Bio Inc 150,0001.4M $
43PepGen Inc 272,892483K $
44KalVista Pharmaceuticals Inc 20,400410.7K $
45REGENXBIO Inc 15,000125.7K $

Download this table: CSV, JSON

Sector breakdown

  • Unattributed 100.0 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • United States 96.9 %
  • France 3.1 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1United States44685.6M $96.85 %
2France122.3M $3.15 %
Cite this page

Titelia. "Holdings of Boxer Capital Management, LLC". https://titelia.com/en/funds/US13F2018299